Expression of bone morphogenetic protein 2, 4, 5, and 7 correlates with histological activity of otosclerotic foci

References

• Chole RA, McKenna M. Pathophysiology of otosclerosis. Otol Neurotol 2001;22:249–57.
   PubMed Web of Science ®Google Scholar
• Stankovic KM, Adachi O, Tsuji K, Kristiansen AG, Adams JC, Rosen V, Differences in gene expression between the otic capsule and other bones. Hear Res 2010;265:83–9.
   PubMed Web of Science ®Google Scholar
• Declau F, Van Spaendonck M, Timmermans JP, Michaels L, Liang J, Qiu JP, Prevalence of otosclerosis in an unselected series of temporal bones. Otol Neurotol 2001;22:596–602.
   PubMed Web of Science ®Google Scholar
• Karosi T, Csomor P, Petkó M, Liktor B, Szabó LZ, Pytel J, Histopathology of nonotosclerotic stapes fixations. Otol Neurotol 2009;30:1058–66.
   PubMed Web of Science ®Google Scholar
• McKenna MJ, Mills BG, Galey FR, Linthicum FH Jr. Filamentous structures morphologically similar to viral nucleocapsids in otosclerotic lesions in two patients. Am J Otol 1986;7:25–8.
   PubMedGoogle Scholar
• Van Den Bogaert K, Govaerts PJ, De Leenheer EM, Schatteman I, Verstreken M, Chen W, Otosclerosis: a genetically heterogeneous disease involving at least three different genes. Bone 2002;30:624–30.
   PubMed Web of Science ®Google Scholar
• McKenna MJ, Kristiansen AG, Bartley ML, Rogus JJ, Haines JL. Association of COL1A1 and otosclerosis: evidence for a shared genetic etiology with mild osteogenesis imperfecta. Am J Otol 1998;19:604–10.
   PubMedGoogle Scholar
• Lehnerdt G, Unkel C, Metz KA, Jahnke K, Neumann A. Immunohistochemical evidence of BMP–2, –4 and –7 activity in otospongiosis. Acta Otolaryngol 2008;128:13–17.
   PubMed Web of Science ®Google Scholar
• Thys M, Schrauwen I, Vanderstraeten K, Janssens K, Dieltjens N, Van Den Bogaert K, The coding polymorphism T263I in TGF-beta1 is associated with otosclerosis in two independent populations. Hum Mol Genet 2007;16:2021–30.
   PubMed Web of Science ®Google Scholar
• Karosi T, Szalmás A, Csomor P, Kónya J, Petkó M, Sziklai I. Disease-associated novel CD46 splicing variants and pathologic bone remodeling in otosclerosis. Laryngoscope 2008;118:1669–76.
   PubMed Web of Science ®Google Scholar
• Schrauwen I, Ealy M, Huentelman MJ, Thys M, Homer N, Vanderstraeten K, A genome-wide analysis identifies genetic variants in the RELN gene associated with otosclerosis. Am J Hum Genet 2009;84:328–38.
   PubMed Web of Science ®Google Scholar
• Lehnerdt G, Metz KA, Trellakis S, Jahnke K, Neumann A. Signaling by way of type IB and II bone morphogenetic protein receptors regulates bone formation in otospongiosis. Laryngoscope 2007;117:812–16.
   PubMed Web of Science ®Google Scholar
• de Gorter DJ, van Dinther M, Korchynskyi O, Ten Dijke P. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation. J Bone Miner Res 2011;26:1178–87.
   PubMed Web of Science ®Google Scholar
• Liu W, Butts S, Kim H, Frenz DA. Negative regulation of otic capsule chondrogenesis: it can make you Smad. Ann N Y Acad Sci 2007;1116:141–8.
   PubMed Web of Science ®Google Scholar
• Brown DJ, Kim TB, Petty EM, Downs CA, Martin DM, Strouse PJ, Autosomal dominant stapes ankylosis with broad thumbs and toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsense and frameshift mutations in NOG, the gene encoding noggin. Am J Hum Genet 2002;71:618–24.
   PubMed Web of Science ®Google Scholar
• Schrauwen I, Thys M, Vanderstraeten K, Fransen E, Dieltjens N, Huyghe JR, Association of bone morphogenetic proteins with otosclerosis. J Bone Miner Res 2008;23:507–16.
   PubMed Web of Science ®Google Scholar
• Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 1994;9:855–63.
   PubMed Web of Science ®Google Scholar
• Zheng MH, Wood DJ, Wysocki S, Papadimitriou JM, Wang EA. Recombinant human bone morphogenetic protein-2 enhances expression of interleukin-6 and transforming growth factor-beta 1 genes in normal human osteoblast-like cells. J Cell Physiol 1994;159:76–82.
   PubMed Web of Science ®Google Scholar
• Karosi T, Jókay I, Kónya J, Petkó M, Szabó LZ, Pytel J, Activated osteoclasts with CD51/61 expression in otosclerosis. Laryngoscope 2006;116:1478–84.
   PubMed Web of Science ®Google Scholar
• Csomor P, Sziklai I, Liktor B, Szabó L, Pytel J, Jóri J, Otosclerosis: disturbed balance between cell survival and apoptosis. Otol Neurotol 2010;31:867–74.
   PubMed Web of Science ®Google Scholar